AC Immune (ACIU) Current Deferred Revenue (2014 - 2024)
AC Immune (ACIU) reported Current Deferred Revenue of $113.21 million for the quarter ended Jun 30, 2026, up 11.9% from $101.13 million a year earlier and up 6.0% from the prior quarter.
Powered by 
Analysis
AC Immune (ACIU) Current Deferred Revenue (2014 - 2024) Analysis & Trends
As of Dec 31, 2025, AC Immune posted Current Deferred Revenue of $100.96 million, up 4.4% from the prior year.
- Current Deferred Revenue has a five-year compound annual growth rate of 214.9% (years ended Dec 2020 to Dec 2025).
- By year, Current Deferred Revenue came in at $96.68 million in the year ended Dec 31, 2024, $153,655 in the year ended Dec 31, 2023 (-75.0%), $615,343 in the year ended Dec 31, 2022 (-21.6%) and $784,648 in the year ended Dec 31, 2021 (+140.5%).
- The figure for the quarter ended Jun 30, 2026 ranks as the highest quarterly Current Deferred Revenue in data going back to the quarter ended Dec 31, 2014.
- Year over year, Current Deferred Revenue has now increased in each of the last five quarters, with growth averaging 8.9% over the last five quarters.
- The high point for year-over-year Current Deferred Revenue in five years was the quarter ended Dec 31, 2021 (growth of 129.7%); the low point was the quarter ended Mar 31, 2024 (a decline of 81.1%).
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $106.8 million (quarter ended Mar 31, 2026), $104.73 million (quarter ended Dec 31, 2025) and $104.61 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.50 Bn | 1,103.09 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 616.20 Bn | 534.73 Bn | 17.26 Bn |
| 3 | AbbVie | 500.82 Bn | 473.93 Bn | 12.70 Bn |
| 4 | Merck | 367.31 Bn | 321.69 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.77 Bn | 261.76 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.35 Bn | 235.04 Bn | 12.86 Bn |
| 7 | Amgen | 235.40 Bn | 190.80 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.59 Bn | 164.79 Bn | 6.22 Bn |
| 9 | Pfizer | 169.39 Bn | 116.04 Bn | 10.94 Bn |
| 10 | AC Immune | 250.87 Mn | -187.53 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 82,124.58 |
| Dec 31, 2023 | 163,631.18 |
| Sep 30, 2023 | 369,495.83 |
| Jun 30, 2023 | 478,234.73 |
| Mar 31, 2023 | 454,356.34 |
| Dec 31, 2022 | 636,073.02 |
| Sep 30, 2022 | 537,474.47 |
| Jun 30, 2022 | 445,408.60 |
| Mar 31, 2022 | 288,200.04 |
| Dec 31, 2021 | 784,721.50 |
| Dec 31, 2020 | 347,104.08 |
| Dec 31, 2019 | 4.62 Mn |
| Dec 31, 2018 | 356,852.38 |
| Sep 30, 2018 | 42,989.62 |
| Jun 30, 2018 | 469,130.58 |
| Mar 31, 2018 | 42,887.03 |
| Dec 31, 2017 | 362,726.06 |
| Sep 30, 2017 | 41,212.47 |
| Jun 30, 2017 | 356,955.92 |
| Mar 31, 2017 | 127,943.70 |
API Access
AC Immune Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ACIU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "ACIU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ACIU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();